C ucumis melo compounds: A new avenue for ALR-2 inhibition in diabetes mellitus.
Alshaghdali K, Tasleem M, Rezgui R, Alharazi T, Acar T, Aljerwan RF, Altayyar A, Siddiqui S, Saeed M, Yadav DK, Saeed A.
Alshaghdali K, et al. Among authors: rezgui r.
Heliyon. 2024 Jul 27;10(15):e35255. doi: 10.1016/j.heliyon.2024.e35255. eCollection 2024 Aug 15.
Heliyon. 2024.
PMID: 39170458
Free PMC article.